Insights from 2024 WCLC
J

WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Therapy Debate in NSCLC

By Insights from 2024 WCLC FEATURING Jan Von Der Thusen
By Insights from 2024 WCLC FEATURING Jan Von Der Thusen
153 views
October 21, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Related Content

AUTOPLAY
08:49

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

2.4K views
17:20

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

1.2K views
35:40

Year in Review: Lung Cancer

Balazs Halmos

2.6K views
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.4K views
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

798 views
18:47

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

6.4K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.1K views
02:41

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

585 views
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

907 views
16:12

2024 Updates on the Fast-Changing NSCLC Landscape

Total Health

R. Osarogiagbon

444 views
25:35

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Total Health

S. Kazmi

4.3K views
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

491 views
26:38

New

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

277 views
13:19

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

E. Rodriguez

2.1K views
11:45

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in …

2024 ASCO® Annual Meeting Insights Hub

T. Mok

439 views
21:24

ADCs and Bispecific Inhibitors in NSCLC

Chul Kim

498 views
30:27

Perioperative Immunotherapy Strategies in Resectable NSCLC After ESM…

Insights from 2023 ESMO Annual Meeting

G. Mountzios

737 views
23:05

Microwave Ablation for Malignant Airway Disease

Fayez Kheir

448 views
09:37

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

Luis Raez

399 views